Medical Dictionary for Regulatory Activities Terminology
Names
More detailed information about this field from each metasource.
Medical Dictionary for Regulatory Activities Terminology
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MedDRA
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
metasource: Biontology / Bioportal
version: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
MEDDRA
metasource: Biontology / Bioportal
version: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Names
More detailed information about this field from each metasource.
Medical Dictionary for Regulatory Activities Terminology
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MedDRA
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
MEDDRA
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Other names: MedDRA, Medical Dictionary for Regulatory Activities Terminology (MedDRA), MEDDRA
Names
More detailed information about this field from each metasource.
Medical Dictionary for Regulatory Activities Terminology
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MedDRA
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
MEDDRA
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
MedDRA is a multilingual terminology allowing most users to operate in their native languages. MedDRA can be used to analyse individual medical events (e.g., “Influenza”) or issues involving a system, organ or etiology (e.g., infections) using its hierarchical structure. MedDRA can be used for signal detection and monitoring of clinical syndromes whose symptoms encompass numerous systems or organs using its multi-axial hierarchy or through the special feature of Standardised MedDRA Queries. The ability to communicate adverse event data is another strength of MedDRA and has lead to MedDRA being an integral part of the ICH e-submission standards: eCTD (ICH M8) and ICSRs (ICH E2B).
Description
More detailed information about this field from each metasource.
MedDRA is a multilingual terminology allowing most users to operate in their native languages. MedDRA can be used to analyse individual medical events (e.g., “Influenza”) or issues involving a system, organ or etiology (e.g., infections) using its hierarchical structure. MedDRA can be used for signal detection and monitoring of clinical syndromes whose symptoms encompass numerous systems or organs using its multi-axial hierarchy or through the special feature of Standardised MedDRA Queries. The ability to communicate adverse event data is another strength of MedDRA and has lead to MedDRA being an integral part of the ICH e-submission standards: eCTD (ICH M8) and ICSRs (ICH E2B).
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
MedDRA is an international medical terminology with an emphasis on use for data entry, retrieval, analysis, and display. It applies to all phases of drug development, excluding animal toxicology, and to the health effects and malfunction of devices. An appendix includes concept descriptions which describe how a medical concept is interpreted, used, and classified within the MedDRA terminology. It is not intended as a medical definition. The concept descriptions are intended to aid the consistent and accurate use of MedDRA in coding, retrieval, and analysis.
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Webpage:
http://www.meddra.org/Webpage
More detailed information about this field from each metasource.
http://www.meddra.org/
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
https://www.meddra.org/
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Licence:
Name: MedDRA Special LicenceLicence name
More detailed information about this field from each metasource.
MedDRA Special Licence
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
The MedDRA ontology is maintained and distributed by the MedDRA MSSO. This ontology is freely accessible on this site for academic and other non-commercial uses. Users anticipating any commercial use of MedDRA must contact the MSSO to obtain a license.
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Licence URL
More detailed information about this field from each metasource.
http://www.meddra.org/subscription/special-licences
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
https://www.meddra.org/about-meddra/organisation/msso
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Publications:
Publications
More detailed information about this field from each metasource.
The medical dictionary for regulatory activities (MedDRA)
PMID: 10082069
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
PMID: 10961570
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
https://www.meddra.org/msso-presentations
metasource: Biontology / Bioportal
version: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
Publications
More detailed information about this field from each metasource.
The medical dictionary for regulatory activities (MedDRA)
PMID: 10082069
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
PMID: 10961570
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
https://www.meddra.org/msso-presentations
metasource: Biontology / Bioportalversion: 2022AA extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/MEDDRA
-
The medical dictionary for regulatory activities (MedDRA)
PubMed citations: 311.
311 articles citing: The medical dictionary for regulatory activities (MedDRA)
Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease. PMID:35836160
Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial. PMID:35802375
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis. PMID:35771411
A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance Database. PMID:35746443
PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature. PMID:35690873
Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center. PMID:35661117
Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial. PMID:35650612
COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning. PMID:35649389
Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database. PMID:35632556
Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations. PMID:35632478
A multimodality intervention to improve musculoskeletal health, function, metabolism, and well-being in spinal cord injury: study protocol for the FIT-SCI randomized controlled trial. PMID:35614404
Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions. PMID:35579819
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data. PMID:35579816
Black Swan Events and Intelligent Automation for Routine Safety Surveillance. PMID:35579807
Protocol of a mixed-method randomised controlled pilot study evaluating a wilderness programme for adolescent and young adult cancer survivors: the WAYA study. PMID:35534081
Risk factors for adverse drug reactions associated with clopidogrel therapy. PMID:35480401
Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects. PMID:35443763
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. PMID:35412032
Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine. PMID:35401219
Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database. PMID:35386045
Intracranial Hemorrhage Following Anticoagulant Treatment in Denmark: Spontaneous Adverse Drug Reaction Reports Versus Real-World Data. PMID:35305263
A knowledge graph of clinical trials ([Formula: see text]). PMID:35304504
Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines. PMID:35214742
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines. PMID:35198288
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study. PMID:35182993
Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database. PMID:35146697
Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events. PMID:35143542
Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China. PMID:35095833
Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews. PMID:35087406
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose. PMID:35087084
Development of a Pipeline for Adverse Drug Reaction Identification in Clinical Notes: Word Embedding Models and String Matching. PMID:35076407
Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany. PMID:34982201
Common osteoporosis drug associated with increased rates of depression and anxiety. PMID:34907232
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database. PMID:34899303
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database. PMID:34776981
Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis. PMID:34673524
Pharmacovigilance Bibliometrics: Visualizing Thematic Development in the Category of Pharmacology and Pharmacy in Web of Science. PMID:34671257
Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry. PMID:34520127
Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System. PMID:34510402
Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: A randomized placebo-controlled trial. PMID:34504764
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study. PMID:34449981
Anaphylactic reactions to local anesthetics in dental practice: a nationwide French retrospective study. PMID:34431002
Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study. PMID:34390273
A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors. PMID:34370076
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. PMID:34349544
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. PMID:34349116
Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases. PMID:34322827
DeepADEMiner: a deep learning pharmacovigilance pipeline for extraction and normalization of adverse drug event mentions on Twitter. PMID:34270701
Informing selection of drugs for COVID-19 treatment through adverse events analysis. PMID:34234253
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. PMID:34162299
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy. PMID:34077634
COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database. PMID:33973280
RadLex Normalization in Radiology Reports. PMID:33936406
Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis. PMID:33907188
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World. PMID:33878105
Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. PMID:33863839
Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020. PMID:33841149
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study. PMID:33739462
Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China. PMID:33639888
Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication. PMID:33631179
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice. PMID:33608749
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. PMID:33590331
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer. PMID:33428586
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. PMID:33364790
Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study. PMID:33350762
Sintilimab: A Promising Anti-Tumor PD-1 Antibody. PMID:33324564
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. PMID:33252992
Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: a 12 week, randomized, double-blind, placebo-controlled clinical trial. PMID:33199752
Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb. PMID:33085778
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study. PMID:33078372
How to interact with medical terminologies? Formative usability evaluations comparing three approaches for supporting the use of MedDRA by pharmacovigilance specialists. PMID:33036603
Artificial Intelligence, Real-World Automation and the Safety of Medicines. PMID:33026641
The 2019 National Natural language processing (NLP) Clinical Challenges (n2c2)/Open Health NLP (OHNLP) shared task on clinical concept normalization for clinical records. PMID:32968800
Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity. PMID:32968055
An interactive retrieval system for clinical trial studies with context-dependent protocol elements. PMID:32946464
Predicting the frequencies of drug side effects. PMID:32917868
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma. PMID:32861537
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration. PMID:32795228
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data. PMID:32788620
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials. PMID:32780229
Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. PMID:32732918
Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events. PMID:32725965
Safety of azithromycin in pediatrics: a systematic review and meta-analysis. PMID:32681202
Mining reported adverse events induced by potential opioid-drug interactions. PMID:32607492
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes. PMID:32601120
Multi-dose Oral Ondansetron for Pediatric Gastroenteritis: study Protocol for the multi-DOSE oral ondansetron for pediatric Acute GastroEnteritis (DOSE-AGE) pragmatic randomized controlled trial. PMID:32460879
Revealing new therapeutic opportunities through drug target prediction: a class imbalance-tolerant machine learning approach. PMID:32399556
Amoxicillin-induced crystal nephropathy: A nationwide French pharmacovigilance databases study. PMID:32353167
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. PMID:32313716
Association of sleep among 30 antidepressants: a population-wide adverse drug reaction study, 2004-2019. PMID:32201646
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018). PMID:32131535
Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy. PMID:32091535
Prediction of Drug-Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities. PMID:32082699
Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews. PMID:32080337
Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. PMID:32066146
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study. PMID:32048185
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial. PMID:32037653
Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer. PMID:31933265
Database of adverse events associated with drugs and drug combinations. PMID:31882773
Broad-Spectrum Profiling of Drug Safety via Learning Complex Network. PMID:31868917
Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels. PMID:31865904
Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics. PMID:31863452
Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports. PMID:31849321
Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study. PMID:31703711
Birth Prevalence of Congenital Cytomegalovirus Infection in HIV-Exposed Uninfected Children in the Era of Combination Antiretroviral Therapy. PMID:31668479
Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database. PMID:31649536
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study. PMID:31630381
RedMed: Extending drug lexicons for social media applications. PMID:31627020
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data. PMID:31605484
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature. PMID:31598933
Ontological and Non-Ontological Resources for Associating Medical Dictionary for Regulatory Activities Terms to SNOMED Clinical Terms With Semantic Properties. PMID:31551780
Development of a neonatal adverse event severity scale through a Delphi consensus approach. PMID:31537552
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. PMID:31501043
Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases. PMID:31468068
Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System. PMID:31428816
The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study. PMID:31361710
Adverse events reported for Mirena levonorgestrel-releasing intrauterine device in France and impact of media coverage. PMID:31218710
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care. PMID:31209934
Time to onset in statistical signal detection revisited: A follow-up study in long-term onset adverse drug reactions. PMID:31189217
The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs. PMID:31184303
Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials. PMID:31156432
A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM. PMID:31144427
Leveraging genetic interactions for adverse drug-drug interaction prediction. PMID:31125330
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System. PMID:31114497
Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PMID:31111881
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). PMID:31073927
Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. PMID:31053734
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study. PMID:31029178
Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis. PMID:30976759
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials. PMID:30974049
Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study. PMID:30941789
Linking entities through an ontology using word embeddings and syntactic re-ranking. PMID:30917789
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs. PMID:30885996
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA. PMID:30871458
Semantic Queries Expedite MedDRA Terms Selection Thanks to a Dedicated User Interface: A Pilot Study on Five Medical Conditions. PMID:30792654
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial. PMID:30676622
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial. PMID:30605211
Predicting adverse drug reactions through interpretable deep learning framework. PMID:30591036
Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017. PMID:30569481
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor. PMID:30427584
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals. PMID:30418214
Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents. PMID:30390234
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder. PMID:30385872
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER. PMID:30305158
Data and systems for medication-related text classification and concept normalization from Twitter: insights from the Social Media Mining for Health (SMM4H)-2017 shared task. PMID:30272184
Advancing the State of the Art in Clinical Natural Language Processing through Shared Tasks. PMID:30157522
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. PMID:30113928
GNOMICS: A one-stop shop for biomedical and genomic data. PMID:29888054
Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs. PMID:29880031
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. PMID:29858838
A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use. PMID:29856848
Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs. PMID:29854250
Detection of Adverse Drug Reactions using Medical Named Entities on Twitter. PMID:29854190
Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases. PMID:29737502
Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. PMID:29695966
Hypericum perforatum to improve post-operative Pain Outcome after monosegmental Spinal microdiscectomy (HYPOS): a study protocol for a randomised, double-blind, placebo-controlled trial. PMID:29695262
Predicting serious rare adverse reactions of novel chemicals. PMID:29617731
Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. PMID:29554173
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. PMID:29514030
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. PMID:29484612
The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability. PMID:29329592
A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands. PMID:29271017
Dramatic Increase of Amoxicillin-Induced Crystal Nephropathy Found in a Cohort Study of French Pharmacovigilance Centers. PMID:29263078
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. PMID:29227175
Identifying natural health product and dietary supplement information within adverse event reporting systems. PMID:29218888
Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research. PMID:29193890
A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study. PMID:29149770
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance. PMID:29143393
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. PMID:29040268
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study). PMID:28956807
Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease. PMID:28916953
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. PMID:28916367
Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets. PMID:28786378
The Microphysiology Systems Database for Analyzing and Modeling Compound Interactions with Human and Animal Organ Models. PMID:28781990
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. PMID:28719598
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database. PMID:28681266
A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria. PMID:28671151
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database. PMID:28664354
CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project. PMID:28657162
Number needed to treat (NNT) in clinical literature: an appraisal. PMID:28571585
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study. PMID:28570723
Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions. PMID:28469412
Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system. PMID:28371826
BRIDG: a domain information model for translational and clinical protocol-driven research. PMID:28339791
Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant. PMID:28327932
Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance. PMID:28235749
The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial. PMID:28077163
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age. PMID:28070861
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement. PMID:28067776
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data. PMID:28063022
GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans. PMID:28013354
The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database. PMID:28002877
Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule. PMID:27803732
Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson's disease. PMID:27796464
Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data. PMID:27751983
Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis. PMID:27749923
Drug-drug interactions with imatinib: An observational study. PMID:27749579
Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases. PMID:27694888
An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders. PMID:27687785
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state. PMID:27677171
A Novel Drug-Mouse Phenotypic Similarity Method Detects Molecular Determinants of Drug Effects. PMID:27673331
Community-based Ontology Development, Annotation and Discussion with MediaWiki extension Ontokiwi and Ontokiwi-based Ontobedia. PMID:27570653
DTMiner: identification of potential disease targets through biomedical literature mining. PMID:27506226
Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research. PMID:27458549
Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection. PMID:27440505
NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease. PMID:27392431
Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment? PMID:27276241
Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada. PMID:27240849
Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events. PMID:27213033
Drug-induced adverse events prediction with the LINCS L1000 data. PMID:27153606
Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms. PMID:27113226
Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events. PMID:27102014
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013. PMID:27087150
Muscle rupture associated with statin use. PMID:27074553
Linking rare and common disease: mapping clinical disease-phenotypes to ontologies in therapeutic target validation. PMID:27011785
The safety of vedolizumab for ulcerative colitis and Crohn's disease. PMID:26893500
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy. PMID:26891968
Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US. PMID:26635479
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. PMID:26448141
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®. PMID:26338346
Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data. PMID:26262375
Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. PMID:25989609
Bias in spontaneous reporting of adverse drug reactions in Japan. PMID:25933226
GraphSAW: a web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data. PMID:25881043
Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles. PMID:25817969
Ranking adverse drug reactions with crowdsourcing. PMID:25800813
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. PMID:25545376
In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases. PMID:25486901
Combining automatic table classification and relationship extraction in extracting anticancer drug-side effect pairs from full-text articles. PMID:25445920
ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms. PMID:25361966
Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. PMID:25249979
Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines. PMID:25191698
A systematic investigation of computation models for predicting Adverse Drug Reactions (ADRs). PMID:25180585
OAE: The Ontology of Adverse Events. PMID:25093068
Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports. PMID:25056801
A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01). PMID:25041377
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis-reply to Pazianas and Abrahamsen. PMID:25035138
Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database. PMID:25027671
Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study. PMID:24923384
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. PMID:24768120
Exploitation of semantic methods to cluster pharmacovigilance terms. PMID:24739596
Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. PMID:24550104
Building a common pediatric research terminology for accelerating child health research. PMID:24534404
From concept representations to ontologies: a paradigm shift in health informatics? PMID:24523987
Automating case definitions using literature-based reasoning. PMID:24454579
Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. PMID:24366502
The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. PMID:24348072
Determining molecular predictors of adverse drug reactions with causality analysis based on structure learning. PMID:24334612
The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines. PMID:24279920
Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department. PMID:24191124
Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS). PMID:24177320
Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database. PMID:24078083
Using empirically constructed lexical resources for named entity recognition. PMID:23847424
Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors. PMID:23748749
Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting. PMID:23728950
Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text. PMID:23703825
Application of information retrieval approaches to case classification in the vaccine adverse event reporting system. PMID:23703591
The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports. PMID:23650490
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. PMID:23640072
Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments. PMID:23616817
Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. PMID:23475583
Sub-lingual immunotherapy: world allergy organization position paper 2009. PMID:23268425
Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France. PMID:22996074
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial. PMID:22724029
Large-scale prediction and testing of drug activity on side-effect targets. PMID:22722194
Early detection of pharmacovigilance signals with automated methods based on false discovery rates: a comparative study. PMID:22612853
Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR. PMID:22527341
Safety profile of enantiomers vs. racemic mixtures: it's the same? PMID:22404187
Chronic kidney disease associated with perinatal HIV infection in children and adolescents. PMID:22366874
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature. PMID:22286160
Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database. PMID:22257367
Determining the reasons for medication prescriptions in the EHR using knowledge and natural language processing. PMID:22195134
Experiences with adverse drug reaction reporting by patients: an 11-country survey. PMID:22149419
Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study. PMID:22143912
The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. PMID:22116460
Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database. PMID:22077504
Translating the Foundational Model of Anatomy into French using knowledge-based and lexical methods. PMID:22029629
Chemical structural novelty: on-targets and off-targets. PMID:21916467
The RICORDO approach to semantic interoperability for biomedical data and models: strategy, standards and solutions. PMID:21878109
Predicting adverse drug reactions using publicly available PubChem BioAssay data. PMID:21613989
A twofold strategy for translating a medical terminology into French. PMID:21346959
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. PMID:21153631
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. PMID:20701410
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. PMID:20533872
Assisting the translation of SNOMED CT into French using UMLS and four representative French-language terminologies. PMID:20351867
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. PMID:19552751
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database. PMID:19530745
An evaluation of three signal-detection algorithms using a highly inclusive reference event database. PMID:19459718
Semantic categories and relations for modelling adverse drug reactions towards a categorial structure for pharmacovigilance. PMID:18998982
Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring. PMID:18636788
Development and application of a framework for maintenance of medical terminological systems. PMID:18579838
Adverse drug reaction reporting by patients in the Netherlands: three years of experience. PMID:18484785
Heterogeneous but "standard" coding systems for adverse events: Issues in achieving interoperability between apples and oranges. PMID:18406213
Data standards in clinical research: gaps, overlaps, challenges and future directions. PMID:17712081
Telithromycin use and spontaneous reports of hepatotoxicity. PMID:17696582
Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions. PMID:16433879
Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methods. PMID:16231957
Clarification of terminology in drug safety. PMID:16180936
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. PMID:16170078
Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). PMID:16048358
Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice. PMID:15651904
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions. PMID:15649103
Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or Hypomania. PMID:15614311
Data quality management in pharmacovigilance. PMID:15366974
Organization and representation of patient safety data: current status and issues around generalizability and scalability. PMID:15298992
Using MedDRA: implications for risk management. PMID:15154830
Application of data mining techniques in pharmacovigilance. PMID:14748811
Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. PMID:12955333
Renal failure associated with the use of celecoxib and rofecoxib. PMID:12093311
Therapeutic ineffectiveness: heads or tails? PMID:12093306
Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART. PMID:12071782 -
The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
PubMed citations: 8.
8 articles citing: The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
A knowledge graph of clinical trials ([Formula: see text]). PMID:35304504
Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches. PMID:31156424
Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. PMID:23843704
A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms. PMID:19007441
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions. PMID:15649103
Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan. PMID:12222991
Prescription-event monitoring in Japan (J-PEM). PMID:12071781
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. PMID:11144660 - https://www.meddra.org/msso-presentations
Tags:
Tags
More detailed information about this field from each metasource.
disease
metasource: Fairsharing.org
version: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Tags
More detailed information about this field from each metasource.
disease
metasource: Fairsharing.orgversion: FAIRsharing.org: MedDRA; Medical Dictionary for Regulatory Activities Terminology; DOI: https://doi.org/10.25504/FAIRsharing.ad3137; Last edited: June 27, 2019, 2 p.m.; Last accessed: Jan 03 2022 7:11 p.m.
Need help integrating and/or managing biomedical data?